ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 102 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133,137 | -44.8% | 25,073 | -1.0% | 0.00% | – |
| Q2 2023 | $241,290 | -8.7% | 25,319 | +5.4% | 0.00% | – |
| Q1 2023 | $264,330 | +6.1% | 24,030 | +42.7% | 0.00% | – |
| Q4 2022 | $249,158 | -30.0% | 16,835 | -9.6% | 0.00% | – |
| Q3 2022 | $356,000 | -92.0% | 18,621 | -91.1% | 0.00% | -100.0% |
| Q2 2022 | $4,458,000 | +1954.4% | 209,175 | +1757.8% | 0.00% | – |
| Q1 2022 | $217,000 | -5.2% | 11,259 | +1.8% | 0.00% | – |
| Q4 2021 | $229,000 | -27.1% | 11,060 | -15.7% | 0.00% | – |
| Q3 2021 | $314,000 | -5.1% | 13,114 | +8.5% | 0.00% | – |
| Q2 2021 | $331,000 | – | 12,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|